当地时间3月18日，丹麦医药巨头诺和诺德背后的企业基金会——诺和诺德基金会宣布，将与全球领先的图形处理器制造商英伟达合作，在丹麦建造一台名为Gefion的AI超级计算机。该计算机将采用英伟达先进的AI技术，旨在加速新药和治疗方法的发现。这台超级计算机将不仅服务于诺和诺德的研究，也向丹麦公共和私营部门的研究人员开放，以促进跨领域合作和创新。
Gefion超级计算机的建设是丹麦在生物技术和人工智能领域的一大投资举措，预计将大大提升丹麦在生命科学领域的研究能力。通过结合高性能计算与AI算法，Gefion将能够处理和分析大量的生物数据，从而加快药物研发的进程。
诺和诺德基金会和英伟达的合作，体现了科技巨头对于推动医疗科技创新的承诺。这不仅有助于加快个体化医疗的发展，还可能为全球健康挑战提供新的解决方案。
英文翻译内容：
Title: Denmark to Build AI Supercomputer for Accelerated Drug Development
Keywords: Novo Nordisk Foundation, NVIDIA, Gefion
News content:
On March 18, the Novo Nordisk Foundation, the corporate foundation behind Danish pharmaceutical giant Novo Nordisk, announced a collaboration with global graphics processing unit manufacturer NVIDIA to construct an AI supercomputer named Gefion in Denmark. The supercomputer will leverage NVIDIA’s cutting-edge AI technology with the goal of accelerating the discovery of new drugs and treatments. Gefion will not only serve Novo Nordisk’s research but will also be available to researchers from both the public and private sectors in Denmark, fostering cross-disciplinary collaboration and innovation.
The construction of Gefion represents a significant investment in Denmark’s biotechnology and AI sectors, expected to significantly enhance the country’s research capabilities in the life sciences. By combining high-performance computing with AI algorithms, Gefion will be able to process and analyze vast amounts of biological data, thus expediting the drug development process.
The partnership between the Novo Nordisk Foundation and NVIDIA underscores the commitment of tech giants to advancing medical innovation. This collaboration is not only expected to accelerate the development of personalized medicine but also to provide new solutions to global health challenges.
【来源】https://www.chinastarmarket.cn/detail/1624366
Views: 1